← Back to headlines
Praxis Precision Medicines Gains Analyst Confidence for Ulixacaltamide
Praxis Precision Medicines, Inc. (PRAX) is gaining analyst confidence regarding its drug Ulixacaltamide.
19 Feb, 08:43 — 19 Feb, 08:43
Read at source (1 outlet)
Related Stories
Africa CDC Advocates for Health Financing Reforms and Local Vaccine Production
9m ago
Nigeria Battles Lassa Fever Outbreak with New Cases and Deaths Reported
19m ago
UNICEF Registers 14 Million Births in Nigeria, Digitalizing System
19m ago
Man's Nightly Bathroom Habit Leads to Prostate Cancer Diagnosis
49m ago